This inventor holds 26 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents, primarily in Fibrosis Treatment. Top assignee: Zymogenetics, Inc.. Active years: 2002-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Seattle, WA (US) (2002 - 2014)
- Lake Forest Park, WA (US) (2011 - 2017)
Company Filing History:
Years Active: 2002-2017
Areas of Expertise:
Title: The Innovative Contributions of Debra G. Gilbertson
Introduction
Debra G. Gilbertson, based in Seattle, WA, is a notable inventor with an impressive portfolio of 26 patents. Her work primarily focuses on advancements in the medical field, particularly in the treatment of neovascular disorders. Her innovative contributions have produced significant advancements in biotechnology, enhancing the understanding of receptor antagonists.
Latest Patents
One of her latest patents includes compositions and methods for inhibiting PDGF receptor β (PDGFRβ) and VEGF-A. This patent discloses antagonists, including neutralizing anti-PDGFRβ and anti-VEGF-A antibodies, alongside bispecific antibodies that can bind and neutralize both PDGFRβ and VEGF-A. These antibodies play a crucial role in the development of methods for treating neovascular disorders, such as cancer or ocular conditions associated with abnormal blood vessel growth.
Career Highlights
Debra has made remarkable strides in her career, working diligently at Zymogenetics, Inc. Her expertise in the field of biotechnology positions her as a leader in her domain, where her research and developments have the potential to revolutionize treatment methods for various medical conditions.
Collaborations
In her professional journey, Debra has collaborated with other esteemed innovators, including Charles E. Hart and Paul O. Sheppard. These partnerships have fostered an environment of innovation and knowledge sharing, further advancing their collective work in the realm of biotechnology and patentable inventions.
Conclusion
Debra G. Gilbertson's innovative contributions and dedication to her field have established her as a prominent figure in medical biotechnology. Her patents are a testament to her commitment to enhancing healthcare and providing new solutions for challenging medical conditions. Through her work at Zymogenetics, Inc., she continues to pave the way for future advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile